The Advanced Prostate Cancer Consensus Conference
Dr. Silke Gillessen and Dr. Aurelius Omlin on the Advanced Prostate Cancer Consensus Conference (APCCC), launched in 2015 to address areas of uncertainty in prostate cancer management. Topics over the years have included oligometastatic disease, treatment sequencing and new imaging. The 2024 APCCC emphasized next-generation imaging, genomic biomarkers, and the balance between innovation and practicality. Looking to 2026, discussions will focus on overtreatment risks, global disparities in imaging access, and incorporating comorbidities into treatment decisions.
